Involving women in HIV vaccine efficacy trials: lessons learned from a vaccine preparedness study in New York City. - Wikidata - wikimedia - TriplyDB

Involving women in HIV vaccine efficacy trials: lessons learned from a vaccine preparedness study in New York City.

Involving women in HIV vaccine efficacy trials: lessons learned from a vaccine preparedness study in New York City.

http://www.wikidata.org/entity/Q30233658

about

Enrolling women into HIV preventive vaccine trials: an ethical imperative but a logistical challenge.Age and sex or gender (sex/gender) and HIV vaccine preparedness.Effect of race/ethnicity on participation in HIV vaccine trials and comparison to other trials of biomedical prevention Enhanced retention strategies and willingness to participate among hard-to-reach female sex workers in Barcelona for HIV prevention and vaccine trials.Using social networks to recruit an HIV vaccine preparedness cohort HIV vaccine preparedness studies in the organization for economic co-operation and development (OECD) countries.HIV vaccine trial preparedness among Spanish-speaking Latinos in the US.In "Step" with HIV Vaccines? A Content Analysis of Local Recruitment Campaigns for an International HIV Vaccine Study Promoting HIV Vaccine Research in African American Communities: Does the Theory of Reasoned Action Explain Potential Outcomes of Involvement?Venue-based recruitment of women at elevated risk for HIV: an HIV Prevention Trials Network study.An extended model of reasoned action to understand the influence of individual- and network-level factors on African Americans' participation in HIV vaccine research.Addressing research priorities for prevention of HIV infection in the United States Reasons for declining to enroll in a phase I and II HIV vaccine trial after randomization among eligible volunteers in Dar es Salaam, Tanzania The potential role of biomarkers in HIV preventive vaccine trials Time will tell: community acceptability of HIV vaccine research before and after the "Step Study" vaccine discontinuation Lessons drawn from recent HIV vaccine efficacy trials.Recruitment of HIV-Positive Women in Research: Discussing Barriers, Facilitators, and Research Personnel's Knowledge Socioecological influences on community involvement in HIV vaccine research Challenges in the design of HIV prevention trials in the United States.Increasing and supporting the participation of persons of color living with HIV/AIDS in AIDS clinical trials Understanding differences in enrollment outcomes among high-risk populations recruited to a phase IIb HIV vaccine trial.Retention strategies and factors associated with missed visits among low income women at increased risk of HIV acquisition in the US (HPTN 064).Follow YOUR Heart: development of an evidence-based campaign empowering older women with HIV to participate in a large-scale cardiovascular disease prevention trial.The effect of peer-driven intervention on rates of screening for AIDS clinical trials among African Americans and Hispanics.Retaining hard-to-reach women in HIV prevention and vaccine trials: Project ACHIEVE Cost-effectiveness analysis of recruitment strategies in a community-based intervention study of HIV-infected persons

P2860

Q25255907-4F8DB4C3-34A0-4B83-9A7B-E6AF64B5A4DA Q30202232-D8D3C516-E94E-4175-81A4-8203B6CC1A8F Q30206105-E082C54B-FC27-42AA-9B94-FDBD3E95A931 Q30223510-D6A8BB44-D5FD-4204-AB6E-F427D294BB07 Q30227795-F515044C-D097-4CF2-971B-74458474FDDC Q30229401-5273B154-6B76-46F4-89F6-EEB35559F2B3 Q30230248-8F6CEF52-6697-4274-8EE2-DF49939CD420 Q30378981-F5E32442-2A37-4EAC-AB8E-8DE691370CCB Q30392323-63D13254-E7C5-4B2E-8314-42BDC872796A Q33714437-1BE2831D-4567-47D9-A4F0-7F819700F11C Q33807022-FBBA560B-8989-41AE-A153-686D58A2DEB5 Q33822456-DFAEDC63-BDB9-4FB2-B157-7E5FA2B0E5CE Q33831829-5968A58D-A025-4A70-9B1B-50CBE50EDE30 Q34059957-7D1D0DEE-955D-4911-A5AE-BF2EDB3FEA91 Q34376994-F8CE2A2E-04EA-43B9-8A03-41C0026E4020 Q34816639-D6CF0C08-AF06-4A39-9C4A-CCCEB14F79DA Q34997670-3B7CAE20-0E59-483C-A570-EBB4699A2F36 Q35207849-43890E84-0E2E-4632-AAC6-BCDA1EC7F496 Q35819672-E5C63427-16D0-4B97-B89F-26FE8774AF10 Q36790642-2F435DFB-44CC-4DCF-9B0B-A86812728C9B Q36853358-E44EA647-D6ED-43A0-B1EE-DA5150395819 Q37701086-9426F040-37AC-41FC-9B03-5F344A145E3F Q40299980-ADFAE27F-D2AA-4610-ACF4-22CA088F3E85 Q55446924-F9C32E75-83C4-4090-9CED-A251582F282A Q57117710-0CD87305-5610-40B3-B793-3500B94A54C4 Q58306670-A1760345-74E6-4760-9D52-2057966E9208

P2860

Involving women in HIV vaccine efficacy trials: lessons learned from a vaccine preparedness study in New York City.

http://www.wikidata.org/entity/Q30233658

description

2000 nî lūn-bûn

@nan

2000 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2000 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2000年の論文

@ja

2000年論文

@yue

2000年論文

@zh-hant

2000年論文

@zh-hk

2000年論文

@zh-mo

2000年論文

@zh-tw

2000年论文

@wuu

name

Involving women in HIV vaccine ...... edness study in New York City.

@ast

Involving women in HIV vaccine ...... edness study in New York City.

@en

type

label

Involving women in HIV vaccine ...... edness study in New York City.

@ast

Involving women in HIV vaccine ...... edness study in New York City.

@en

prefLabel

Involving women in HIV vaccine ...... edness study in New York City.

@ast

Involving women in HIV vaccine ...... edness study in New York City.

@en

P1433

Q30233658-32D0CF54-1FFD-431E-A36E-49F8F8EC8370

P1476

Q30233658-F7CB2725-3B50-459F-98A6-C67A92B3B052

P2093

Q30233658-4807711B-A9F3-4AD2-BCED-CA6E8FBBAD22

Q30233658-AC20C2F5-C0E0-474E-B106-3A8BFA547257

Q30233658-DF384087-6232-4FBF-BC0F-8C86D53CE02D

Q30233658-F6CBADF8-C065-4C67-85BF-A4274D4AA4D9

P2860

Q30233658-019999AE-3372-4329-9EBD-C985F2FA2184

Q30233658-0572B0C5-B36B-42DE-9381-FFF3EF5E6333

Q30233658-7EF86E93-87B0-4984-8E3D-73C9BBE4CE0E

Q30233658-C2AD934D-A160-4976-851F-F69ED07FB759

Q30233658-C44408CF-4845-424A-AE1B-5C0B18176EE4

Q30233658-E1CF57DD-3D38-429A-9BF3-AF31233241EA

Q30233658-E78AECFF-5AAD-4CDD-900F-67208EB19365

Q30233658-F939D3DF-3CF4-4606-9D38-9CFE556DC455

P2888

Q30233658-B218FC9C-3401-4F91-938B-67C766DF2C6D

P304

Q30233658-C6A29FB5-7031-4043-AE04-EE0A0AA4FC2B

P31

Q30233658-B3474391-6ED8-46DF-9B70-7D0BE4DA1532

P356

Q30233658-16F2B351-9A63-437A-A90C-0EA1E94FD0E5

P433

Q30233658-4AD6B7C3-F436-4B22-A05F-434A4D79E860

P478

Q30233658-5C31C610-5420-4ED4-8C1D-DF6C5C1063F2

P577

Q30233658-5D7E37A2-B7EF-4425-A19E-6888B0FCD9F7

P698

Q30233658-A26CBBC8-1F6B-432E-8B20-7C3924E73DFF

P932

Q30233658-EC34CAEE-5EDF-4F55-81F8-624231612C75

P356

P1433

Journal of Urban Health

P1476

Involving women in HIV vaccine ...... edness study in New York City.

@en

P2093

B A Koblin

http://www.w3.org/2001/XMLSchema#string

L Ren

http://www.w3.org/2001/XMLSchema#string

M A Chiasson

http://www.w3.org/2001/XMLSchema#string

P Brown-Peterside

http://www.w3.org/2001/XMLSchema#string

P2860

Readiness of high-risk populations in the HIV Network for Prevention Trials to participate in HIV vaccine efficacy trials in the United States.

15-month followup of women methadone patients taught skills to reduce heterosexual HIV transmission.

Willingness to participate in HIV-1 vaccine efficacy trials and the effect of media events among gay and bisexual men in New York City: Project ACHIEVE.

The challenge of minority recruitment in clinical trials for AIDS.

Candidate AIDS vaccines.

Strategies for addressing the social and behavioral challenges of prophylactic HIV vaccine trials.

Retaining and tracking cohort study members.

Women's health research: public policy and sociology.

P2888

P304

425-437

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/BF02386751

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

77

http://www.w3.org/2001/XMLSchema#string

P577

2000-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

10976615

http://www.w3.org/2001/XMLSchema#string

P932

3456036

http://www.w3.org/2001/XMLSchema#string